Orexo AB - Company & Market Research Reports

Orexo AB is a specialty pharmaceutical company in the United States. Its launched products include Zubsolv sublingual tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar, an active substance zolpidem that is used for the treatment of short-term insomnia. It has collaboration agreement with Mundipharma for the development and commercialization of Zubsolv and with AstraZeneca with regards to the OX-Cysteinyl Leukotriene Inhibitor project. Founded in 1995, the company is headquartered in Uppsala, Sweden.

CNS Cluster Addiction Drug Development Pipeline Review, 2017 - Product Thumbnail Image

CNS Cluster Addiction Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays  - Detailed Analysis On Technologies And Pipeline Development - Product Thumbnail Image

Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays - Detailed Analysis On Technologies And Pipeline Development

  • Report
  • 70 Pages
From
Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 340 Pages
From
Zubsolv 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Zubsolv 2017 U.S. Promotional Audit Report

  • Report
  • 32 Pages
From
Global Cancer Pain Therapeutics Market 2015-2019 - Product Thumbnail Image

Global Cancer Pain Therapeutics Market 2015-2019

  • Report
  • 61 Pages
From
PDE Inhibitors Market, 2016-2026 - Product Thumbnail Image

PDE Inhibitors Market, 2016-2026

  • Report
  • 223 Pages
From
Analgesics - Global Strategic Business Report - Product Thumbnail Image

Analgesics - Global Strategic Business Report

  • Report
  • 767 Pages
From
Opium (Opioid) Addiction - Pipeline Review, H2 2018 - Product Thumbnail Image

Opium (Opioid) Addiction - Pipeline Review, H2 2018

  • Drug Pipelines
  • 121 Pages
From
Drug Overdose - Pipeline Review, H2 2018 - Product Thumbnail Image

Drug Overdose - Pipeline Review, H2 2018

  • Drug Pipelines
  • 65 Pages
From
Memory Impairment Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Memory Impairment Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 96 Pages
From
Opium (Opioid) Addiction - Pipeline Review, H1 2018 - Product Thumbnail Image

Opium (Opioid) Addiction - Pipeline Review, H1 2018

  • Drug Pipelines
  • 109 Pages
From
Pain Management- New Discoveries And Treatment Options In Abuse Deterrent Era - Product Thumbnail Image

Pain Management- New Discoveries And Treatment Options In Abuse Deterrent Era

  • Report
  • 135 Pages
From
United States Pain Management Therapeutics Market, Patients Volume, and 50 Company's Pipeline Analysis (By Product, Indication, Phase of Development) - Product Thumbnail Image

United States Pain Management Therapeutics Market, Patients Volume, and 50 Company's Pipeline Analysis (By Product, Indication, Phase of Development)

  • Report
  • 77 Pages
From
Age Related Memory Impairment Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Age Related Memory Impairment Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 43 Pages
From
Aneurysmal Subarachnoid Hemorrhage Drugs Market by Drug Class - Global Opportunity Analysis and Industry Forecast, 2017-2023 - Product Thumbnail Image

Aneurysmal Subarachnoid Hemorrhage Drugs Market by Drug Class - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Report
  • 142 Pages
From
Acute Pain - Pipeline Review, H2 2016 - Product Thumbnail Image

Acute Pain - Pipeline Review, H2 2016

  • Drug Pipelines
  • 194 Pages
From
Oral Thin Films Market, 2015 - 2025 - Product Thumbnail Image

Oral Thin Films Market, 2015 - 2025

  • Report
  • 249 Pages
From
Acute Pain - Pipeline Review, H1 2016 - Product Thumbnail Image

Acute Pain - Pipeline Review, H1 2016

  • Drug Pipelines
  • 202 Pages
From
Anti-Migraine Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Migraine Drugs - Global Strategic Business Report

  • Report
  • 580 Pages
From
The Top 50 Developers Of Pain Management Pharmaceuticals Worldwide - Product Thumbnail Image

The Top 50 Developers Of Pain Management Pharmaceuticals Worldwide

  • Report
  • 235 Pages
From
Loading Indicator
adroll